Dolby Laboratories Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

Dolby Laboratories şirketinin toplam hissedar öz sermayesi $2.4B ve toplam borcu $0.0 olup, bu da borç-öz sermaye oranını 0% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla $3.0B ve $526.2M dir. Dolby Laboratories 'in FAVÖK'ü $246.7M faiz karşılama oranı -6.8 dur. Şirketin $869.0M tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

0%

Borç/özkaynak oranı

US$0

Borç

Faiz karşılama oranı-6.8x
NakitUS$868.96m
EşitlikUS$2.45b
Toplam yükümlülüklerUS$526.20m
Toplam varlıklarUS$2.97b

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

Dolby Laboratories (NYSE:DLB) Hasn't Managed To Accelerate Its Returns

Oct 28
Dolby Laboratories (NYSE:DLB) Hasn't Managed To Accelerate Its Returns

Is There Now An Opportunity In Dolby Laboratories, Inc. (NYSE:DLB)?

Sep 22
Is There Now An Opportunity In Dolby Laboratories, Inc. (NYSE:DLB)?

Dolby Laboratories: Need To See Improvements In Sales Before Committing Capital

Aug 22

Dolby Laboratories, Inc.'s (NYSE:DLB) Share Price Matching Investor Opinion

Aug 13
Dolby Laboratories, Inc.'s (NYSE:DLB) Share Price Matching Investor Opinion

We Like These Underlying Return On Capital Trends At Dolby Laboratories (NYSE:DLB)

Jul 26
We Like These Underlying Return On Capital Trends At Dolby Laboratories (NYSE:DLB)

Dolby Laboratories: A Sound Player, Trading At A Too-Rich Valuation

Jun 10

Should You Think About Buying Dolby Laboratories, Inc. (NYSE:DLB) Now?

Jun 07
Should You Think About Buying Dolby Laboratories, Inc. (NYSE:DLB) Now?

Dolby Laboratories Remains A Hold

May 14

Dolby Laboratories, Inc. (NYSE:DLB) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year

May 05
Dolby Laboratories, Inc. (NYSE:DLB) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year

Dolby Laboratories, Inc.'s (NYSE:DLB) Earnings Haven't Escaped The Attention Of Investors

May 02
Dolby Laboratories, Inc.'s (NYSE:DLB) Earnings Haven't Escaped The Attention Of Investors

Investors Will Want Dolby Laboratories' (NYSE:DLB) Growth In ROCE To Persist

Apr 16
Investors Will Want Dolby Laboratories' (NYSE:DLB) Growth In ROCE To Persist

Dolby Laboratories, Inc. (NYSE:DLB) Shares Could Be 26% Below Their Intrinsic Value Estimate

Mar 17
Dolby Laboratories, Inc. (NYSE:DLB) Shares Could Be 26% Below Their Intrinsic Value Estimate

Dolby Laboratories Sees Flat Revenue Ahead (Downgrade)

Mar 01

Dolby Laboratories' (NYSE:DLB) Earnings Offer More Than Meets The Eye

Feb 09
Dolby Laboratories' (NYSE:DLB) Earnings Offer More Than Meets The Eye

What Is Dolby Laboratories, Inc.'s (NYSE:DLB) Share Price Doing?

Jan 31
What Is Dolby Laboratories, Inc.'s (NYSE:DLB) Share Price Doing?

With Dolby Laboratories, Inc. (NYSE:DLB) It Looks Like You'll Get What You Pay For

Jan 15
With Dolby Laboratories, Inc. (NYSE:DLB) It Looks Like You'll Get What You Pay For

The Return Trends At Dolby Laboratories (NYSE:DLB) Look Promising

Dec 28
The Return Trends At Dolby Laboratories (NYSE:DLB) Look Promising

Dolby Laboratories: On A Positive Hold As Shareholder Rewards Continue

Dec 06

A Look At The Fair Value Of Dolby Laboratories, Inc. (NYSE:DLB)

Nov 18
A Look At The Fair Value Of Dolby Laboratories, Inc. (NYSE:DLB)

At US$81.66, Is Dolby Laboratories, Inc. (NYSE:DLB) Worth Looking At Closely?

Oct 11
At US$81.66, Is Dolby Laboratories, Inc. (NYSE:DLB) Worth Looking At Closely?

Dolby Laboratories: High P/E Is Not Justified, A Hold For Now

Sep 13

The Returns At Dolby Laboratories (NYSE:DLB) Aren't Growing

Aug 03
The Returns At Dolby Laboratories (NYSE:DLB) Aren't Growing

What Is Dolby Laboratories, Inc.'s (NYSE:DLB) Share Price Doing?

Jul 12
What Is Dolby Laboratories, Inc.'s (NYSE:DLB) Share Price Doing?

Dolby Laboratories Sees Return To Growth Ahead

Jun 22

Returns On Capital At Dolby Laboratories (NYSE:DLB) Paint A Concerning Picture

May 04
Returns On Capital At Dolby Laboratories (NYSE:DLB) Paint A Concerning Picture

A Look At The Intrinsic Value Of Dolby Laboratories, Inc. (NYSE:DLB)

Apr 14
A Look At The Intrinsic Value Of Dolby Laboratories, Inc. (NYSE:DLB)

Is There Now An Opportunity In Dolby Laboratories, Inc. (NYSE:DLB)?

Mar 29
Is There Now An Opportunity In Dolby Laboratories, Inc. (NYSE:DLB)?

Dolby Laboratories goes ex-dividend on Monday

Feb 10

Dolby Laboratories FQ1 2023 Earnings Preview

Feb 01

Dolby Laboratories (NYSE:DLB) Could Be At Risk Of Shrinking As A Company

Jan 24
Dolby Laboratories (NYSE:DLB) Could Be At Risk Of Shrinking As A Company

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: DLB 'nin kısa vadeli varlıkları ( $1.5B ) kısa vadeli yükümlülüklerini ( $354.5M ) aşıyor.

Uzun Vadeli Yükümlülükler: DLB şirketinin kısa vadeli varlıkları ( $1.5B ) uzun vadeli yükümlülüklerini ( $171.7M ) aşmaktadır.


Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: DLB borçsuzdur.

Borcun Azaltılması: DLB son 5 yıldır borcu bulunmamaktadır.

Borç Kapsamı: DLB un borcu yoktur, dolayısıyla işletme nakit akışı tarafından karşılanmasına gerek yoktur.

Faiz Kapsamı: DLB şirketinin borcu bulunmadığından faiz ödemelerinin karşılanması söz konusu değildir.


Bilanço


Sağlıklı şirketleri keşfedin